1. Home
  2. GOSS vs SCHL Comparison

GOSS vs SCHL Comparison

Compare GOSS & SCHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • SCHL
  • Stock Information
  • Founded
  • GOSS 2015
  • SCHL 1920
  • Country
  • GOSS United States
  • SCHL United States
  • Employees
  • GOSS N/A
  • SCHL N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • SCHL Books
  • Sector
  • GOSS Health Care
  • SCHL Consumer Discretionary
  • Exchange
  • GOSS Nasdaq
  • SCHL Nasdaq
  • Market Cap
  • GOSS 586.6M
  • SCHL 644.1M
  • IPO Year
  • GOSS 2019
  • SCHL 1987
  • Fundamental
  • Price
  • GOSS $3.08
  • SCHL $27.54
  • Analyst Decision
  • GOSS Strong Buy
  • SCHL Strong Buy
  • Analyst Count
  • GOSS 6
  • SCHL 1
  • Target Price
  • GOSS $8.60
  • SCHL $37.00
  • AVG Volume (30 Days)
  • GOSS 4.8M
  • SCHL 270.3K
  • Earning Date
  • GOSS 11-06-2025
  • SCHL 09-18-2025
  • Dividend Yield
  • GOSS N/A
  • SCHL 2.90%
  • EPS Growth
  • GOSS N/A
  • SCHL N/A
  • EPS
  • GOSS N/A
  • SCHL N/A
  • Revenue
  • GOSS $40,237,000.00
  • SCHL $1,625,500,000.00
  • Revenue This Year
  • GOSS N/A
  • SCHL $4.15
  • Revenue Next Year
  • GOSS $34.10
  • SCHL $3.96
  • P/E Ratio
  • GOSS N/A
  • SCHL N/A
  • Revenue Growth
  • GOSS N/A
  • SCHL 2.25
  • 52 Week Low
  • GOSS $0.66
  • SCHL $15.77
  • 52 Week High
  • GOSS $3.60
  • SCHL $34.18
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 61.72
  • SCHL 63.46
  • Support Level
  • GOSS $2.93
  • SCHL $26.69
  • Resistance Level
  • GOSS $3.37
  • SCHL $28.20
  • Average True Range (ATR)
  • GOSS 0.29
  • SCHL 0.99
  • MACD
  • GOSS 0.01
  • SCHL 0.06
  • Stochastic Oscillator
  • GOSS 57.55
  • SCHL 82.72

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About SCHL Scholastic Corporation

Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.

Share on Social Networks: